BioSpace News Archive

Peptide Logic, a biopharmaceutical company developing peptide-antibody conjugates (PACs) for pain (www.peptidelogic.com), announced today that it was awarded up to $ 3.0 million in a Small Business Innovation Research (SBIR) Phase II grant to develop novel, non-addictive, peripherally-restricted, and long-acting somatostatin receptor 4 (LA‑SSTR4) agonists for the treatment of moderate-to-severe pain reducing the need for opioid use

On September 19th, Steinberg Diagnostic Medical Imaging (SDMI) officially broke ground on their 9th location in Southern Nevada

On October 2nd, 2019, Brandx Medica announced its official launch, opening patient acquisition services for doctors and medical practices in Scottsdale, Arizona, Beverly Hills, California, New York City, New York, and Las Vegas, Nevada.

In stark contrast to Democrats who seek to push all Americans into socialized medicine, an Executive Order signed on October 3 by President Donald Trump takes bold steps toward increasing the ability of American seniors to choose the medical care and insurance options best for them, instead of being trapped within increasingly insolvent government-run programs.

Amylyx Pharmaceuticals, Inc., a clinical-stage pharmaceutical company focused on developing new treatments for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, today announced that the last participant has completed the planned 24 weeks of study treatment in CENTAUR, a clinical trial assessing the safety and efficacy of AMX0035 in people with ALS.

Over the past several weeks, the U.S. Food and Drug Administration has been working tirelessly along with the U.S. Centers for Disease Control and Prevention and other federal, state and local partners to investigate the distressing incidents of severe lung injuries and deaths associated with the use of vaping products.

Galderma, a global leader focused on meeting the world’s increasing skin health needs, announced today that the U.S. Food and Drug Administration (FDA) approved AKLIEF® (trifarotene) Cream, 0.005% for the topical treatment of acne.

Waters Corporation (NYSE:WAT) will webcast its Q3 2019 financial results conference call live on Tuesday, October 29th at 8:00 a.m. eastern time.

Since its inception, Paragon 28® has obsessed over every aspect of foot and ankle surgery.

Curis, Inc. announced that on October 1, 2019, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase a total of 157,500 shares of Curis common stock to two new employees, with a grant date of October 1, 2019.